EuroPrevent 2018,cardiovascular prevention at its highest levels

Abstract

Get full access to this article

View all access options for this article.

References

Radtke

Poerschke

Wilhelm

et al.

Acute effects of Finnish sauna and cold-water immersion on haemodynamic variables and autonomic nervous system activity in patients with heart failure. Eur J Prev Cardiol 2016; 23: 593–601.

Lee

Laukkanen

Kunutsor

et al.

Sauna exposure leads to improved arterial compliance: Findings from a non-randomised experimental study. Eur J Prev Cardiol 2018; 25: 130–138.

Kunutsor

Khan

Laukkanen

et al.

Joint associations of sauna bathing and cardiorespiratory fitness on cardiovascular and all-cause mortality risk: A long-term prospective cohort study. Ann Med 2018; 50: 139–146.

Schmid

Noveanu

Morger

et al.

Influence of water immersion, water gymnastics and swimming on cardiac output in patients with heart failure. Heart 2007; 93: 722–727.

Gupta

Sawhney

Rai

et al.

Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients – Mount Abu Open Heart Trial. Indian Heart J 2011; 63: 461–469.

Manchanda

Narang

Reddy

et al.

Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Physicians India 2000; 48: 687–694.

Krishna

Pal

et al.

A randomized controlled trial to study the effect of yoga therapy on cardiac function and N terminal pro BNP in heart failure. Integr Med Insights 2014; 9: 1–6.

Deutsch

Krivitsky

. The impact of yoga on atrial fibrillation: A review of The Yoga My Heart Study. J Arrhythm 2015; 31: 337–338.

Banach M, Patti AM, Giglio VR, et al. The role of nutraceuticals in statin intolerant patients: Position paper from an international lipid expert panel. J Am Coll Cardiol (in press).

10.

Marazzi

Campolongo

Pelliccia

et al.

Comparison of low-dose statin versus low-dose statin + armolipid plus in high-intensity statin-intolerant patients with a previous coronary event and percutaneous coronary intervention (ADHERENCE Trial). Am J Cardiol 2017; 15; 120: 893–897.

11.

Barrios

Escobar

Cicero

et al.

A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence. Atheroscler Suppl 2017; 24: 1–15.

12.

Cicero

AFG

Colletti

Bajraktari

et al.

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci 2017; 13: 965–1005.

13.

Prescott

Meindersma

van der Velde

et al.

A European study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly: Design of the EU-CaRE randomised controlled trial. Eur J Prev Cardiol 2016; 23(2 Suppl.): 27–40.

14.

Brouwers

Kraal

Traa

et al.

Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: Protocol for the SmartCare-CAD randomised controlled trial. BMC Cardiovasc Disord 2017; 17: 46–46.

15.

Frederix

Vandenberk

Janssen

et al.

eEduHeart I: A multicenter, randomized, controlled trial investigating the effectiveness of a cardiac web-based elearning platform – rationale and study design. Cardiology 2017; 136: 157–163.

16.

Rawstorn

Gant

Meads

et al.

Remotely delivered exercise-based cardiac rehabilitation: Design and content development of a novel mHealth platform. JMIR Mhealth Uhealth 2016; 4: e57–e57.

17.

Finocchiaro

Papadakis

Robertus

et al.

Etiology of sudden death in sports: Insights from a United Kingdom regional registry. J Am Coll Cardiol 2016; 67: 2108–2115.

18.

Basu-Ray

Liu

Jia

et al.

Subcutaneous versus transvenous implantable defibrillator therapy. A meta-analysis of case–control studies. JACC Clin Electrophysiol 2017; 3: 1475–1483.

19.

Lampert

Olshansky

Heidbuchel

et al.

Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry. Circulation 2013; 127: 2021–2030.

20.

Link

Bockstall

Weinstock

et al.

Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy and defibrillators: Triggers, treatment, and implications. J Cardiovasc Electrophysiol 2017; 28: 531–537.

21.

Francia

Adduci

Palano

et al.

Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2015; 26: 893–899.

22.

Adami

Negro

Lala

et al.

The role of physical activity in the prevention and treatment of chronic diseases. Clin Ter 2010; 161: 537–541.

23.

World Health Organization. 71st World Health Assembly resolution, global action plan on physical activity 2018–2030. More active people for a healthier world (agenda item 12.2), http://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_18-en.pdf (2018, accessed 1 June 2018).

24.

Pattyn

Vanhees

Cornelissen

et al.

The long-term effects of a randomized trial comparing aerobic interval versus continuous training in coronary artery disease patients: 1-year data from the SAINTEX-CAD study. Eur J Prev Cardiol 2016; 23: 1154–1164.

25.

D'Ascenzi F, Adami PE, Eichler S, et al. The Young Community of the European Association of Preventive Cardiology: The future in motion. Eur J Prev Cardiol 2018; 25: 567–568.

26.

Perrone

Sangiorgi

Buda

et al.

Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: Retrospective study. Clinicoecon Outcomes Res 2016; 8: 649–655.

27.

Turnbull

Abraira

Anderson

et al.

Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288–2298.